Many men diagnosed with prostate cancer (PC) have non-aggressive, localized tumors that progress slowly over time. As a result, the use of active surveillance (AS) has grown in these men with low-risk tumors that are unlikely to rapidly progress, and about half of men newly diagnosed with PC are eligible for AS. Integrative medicine may offer men undertaking AS a number of evidence-based interventions that allow them to participate more fully in their own care. This article reviews the evidence basis for these interventions. This includes lifestyle change utilizing diet and exercise, and the use of targeted natural substances such as soy isoflavones, pomegranate, dietary omega 3 fatty acids, sulforaphane, medicinal mushrooms, and Vitamin D.
Get full access to this article
View all access options for this article.
References
1.
PunnenS, CarrollPR, WashingtonSL. Active Surveillance for Males with Clinically Localized Prostate Cancer—UpToDate. UpToDate Waltham, MA, 2023.
2.
GreggJR, ZhengJ, LopezDS, et al.Diet quality and Gleason grade progression among localised prostate cancer patients on active surveillance. Br J Cancer, 2019; 120:466–471.
3.
CooperbergMR, MeeksW, FangR, et al.time trends and variation in the use of active surveillance for management of low-risk prostate cancer in the US. JAMA Netw Open, 2023; 6:e231439.
4.
Al AwamlhBAH, BarocasDA, ZhuA, et al.Use of active surveillance vs definitive treatment among men with low- and favorable intermediate–risk prostate cancer in the US between 2010 and 2018. JAMA Intern Med, 2023; 183:608–611.
5.
TosoianJJ, MamawalaM, EpsteinJI, et al.Active Surveillance of Grade Group 1 Prostate Cancer: Long-term outcomes from a Large Prospective Cohort. Eur Urol, 2020; 77:675–682.
6.
GohAC, KowalkowskiMA, BaileyDE, et al.Perception of cancer and inconsistency in medical information are associated with decisional conflict: A pilot study of men with prostate cancer who undergo active surveillance. BJU Int, 2012; 110:E50-6.
7.
OromH, HomishDL, HomishGG, et al.Quality of physician-patient relationships is associated with the influence of physician treatment recommendations among patients with prostate cancer who chose active surveillance. Urol Oncol, 2014; 32:396–402.
8.
HoffmanRM, Van Den EedenSK, DavisKM, et al.Decision-making processes among men with low-risk prostate cancer: A survey study. Psychooncology, 2018; 27:325–332.
9.
OromH, UnderwoodW, BiddleC. Emotional distress increases the likelihood of undergoing surgery among men with localized prostate cancer. J Urol, 2017; 197:350–355.
10.
BergerZD, YehJC, CarterHB, et al.Characteristics and experiences of patients with localized prostate cancer who left an Active Surveillance Program. Patient, 2014; 7:427.
11.
SchulzGB, LockeJA, CampbellKL, et al.Taking advantage of the teachable moment at initial diagnosis of prostate cancer—Results of a Pilot Randomized Controlled Trial of Supervised Exercise Training. Cancer Nurs, 2022; 45:E680–E688.
12.
AveryKNL, DonovanJL, HorwoodJ, et al.The importance of dietary change for men diagnosed with and at risk of prostate cancer: A multi-centre interview study with men, their partners and health professionals. BMC Fam Pract, 2014; 15:81.
13.
KinsellaN, BeckmannK, CahillD, et al.A single educational seminar increases confidence and decreases dropout from active surveillance by 5 years after diagnosis of prostate cancer. Eur Urol Oncol, 2019; 2:464–470.
14.
GalvãoDA, ChambersSK. Exercise medicine in men with prostate cancer: Breaking barriers to increase participation. Prostate Cancer Prostatic Dis, 2021; 24:942–943.
15.
KangDW, FaireyAS, BouléNG, et al.Effects of exercise on cardiorespiratory fitness and biochemical progression in men with localized prostate cancer under active surveillance: The ERASE Randomized Clinical Trial. JAMA Oncol, 2021; 7:1487.
16.
GreggJR, ZhangX, ChapinBF, et al.Adherence to the Mediterranean diet and grade group progression in localized prostate cancer: An active surveillance cohort. Cancer, 2021; 127:720–728.
17.
SchenkJM, LiuM, NeuhouserML, et al.Dietary patterns and risk of Gleason Grade Progression among men on active surveillance for prostate cancer: Results from the Canary Prostate Active Surveillance Study. Nutr Cancer, 2023; 75:618–626.
18.
AjdžanovićV, FilipovićB, MiljićD, et al.Prostate cancer metastasis and soy isoflavones: A dogfight over a bone. EXCLI J, 2019; 18:106–126.
19.
RanjithkumarR, SaravananK, BalajiB, et al.Novel daidzein molecules exhibited anti-prostate cancer activity through nuclear receptor ERβ modulation, in vitro and in vivo studies. J Chemother, 2021; 33:582–594.
20.
LinX, GingrichJR, BaoW, et al.Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice. Urology, 2002; 60:919–924.
21.
NomikosT, GiotiK, TsoukalaM, et al.Pumpkin seed extracts inhibit proliferation and induce autophagy in PC-3 androgen insensitive prostate cancer cells. J Med Food, 2021; 24:1076–1082.
22.
MedjakovicS, HobigerS, Ardjomand-WoelkartK, et al.Pumpkin seed extract: Cell growth inhibition of hyperplastic and cancer cells, independent of steroid hormone receptors. Fitoterapia, 2016; 110:150–156.
23.
KumarNB, DickinsonSI, SchellMJ, et al.Green tea extract for prevention of prostate cancer progression in patients on active surveillance. Oncotarget, 2018; 9:37798.
24.
WangX, HaD, MoriH, et al.White button mushroom (Agaricus bisporus) disrupts androgen receptor signaling in human prostate cancer cells and patient-derived xenograft. J Nutr Biochem, 2021; 89:108580.
25.
FrenchC, ChandraLC, ClarkeS, et al.The inhibitory properties of ethanol extracts of some culinary-medicinal mushrooms on the secretion of interleukin-8 and vascular endothelial growth factor by PC3 cancer cells. Int J Med Mushrooms, 2019; 21:645–656.
26.
YamashitaSN, TanakaY, KitagawaT, et al.Down-regulating effect of a standardized extract of cultured lentinula edodes mycelia on cortactin in prostate cancer cells is dependent on malignant potential. Anticancer Res, 2023; 43:1159–1166.
27.
ChavesFM, PavanICB, da SilvaLGS, et al.Pomegranate juice and peel extracts are able to inhibit proliferation, migration and colony formation of prostate cancer cell lines and modulate the Akt/mTOR/S6K Signaling Pathway. Plant Foods Hum Nutr, 2020; 75:54–62.
28.
FarhanM, RizviA, AliF, et al.Pomegranate juice anthocyanidins induce cell death in human cancer cells by mobilizing intracellular copper ions and producing reactive oxygen species. Front Oncol, 2022; 12:998346.
29.
BolatZB, IslekZ, SahinF, et al.Delivery of curcumin within emulsome nanoparticles enhances the anti-cancer activity in androgen-dependent prostate cancer cell. Mol Biol Rep, 2023; 50:2531–2543.
30.
AlhasawiMAI, AatifM, MuteebG, et al.Curcumin and its derivatives induce apoptosis in human cancer cells by mobilizing and redox cycling genomic copper ions. Molecules, 2022; 27:7410.
31.
LeeYJ, LeeSH. ERK1/2-dependent inhibition of glycolysis in curcumin-induced cytotoxicity of prostate carcinoma cells. Biomed Res Int, 2022; 2022:7626405.
32.
SinghKB, HahmER, AlumkalJJ, et al.Reversal of the Warburg phenomenon in chemoprevention of prostate cancer by sulforaphane. Carcinogenesis, 2019; 40:1545–1556.
33.
RutzJ, ThalerS, MaxeinerS, et al.Sulforaphane reduces prostate cancer cell growth and proliferation in vitro by modulating the Cdk-Cyclin axis and expression of the CD44 variants 4, 5, and 7. Int J Mol Sci, 2020; 21:1–14.
34.
BeaverLM, LöhrCV, ClarkeJD, et al.Broccoli sprouts delay prostate cancer formation and decrease prostate cancer severity with a concurrent decrease in HDAC3 protein expression in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice. Curr Dev Nutr, 2017; 2:nzy002.
35.
MoranNE, Thomas-AhnerJM, WanL, et al.Tomatoes, lycopene, and prostate cancer: What have we learned from experimental models?. J Nutr, 2022; 152:1381.
36.
DeVere WhiteRW, TsodikovA, StappEC, et al.Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer. Nutr Cancer, 2010; 62:1036.
37.
DeVere WhiteRW, HackmanRM, SoaresSE, et al.Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer. Urology, 2004; 63:259–263.
38.
ZarfeshanyA, AsgaryS, JavanmardSH. Potent health effects of pomegranate. Adv Biomed Res, 2014; 3:100.
39.
JarrardD, FilonM, HuangW, et al.A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance. Prostate, 2021; 81:41–49.
40.
PallerCJ, YeX, WozniakPJ, et al.A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer. Prostate Cancer Prostatic Dis, 2013; 16:50–55.
41.
TrakaMH, MelchiniA, Coode-BateJ, et al.Transcriptional changes in prostate of men on active surveillance after a 12-mo glucoraphanin-rich broccoli intervention-results from the Effect of Sulforaphane on prostate CAncer PrEvention (ESCAPE) randomized controlled trial. Am J Clin Nutr, 2019; 109:1133–1144.
42.
YagishitaY, FaheyJW, Dinkova-KostovaAT, et al.Broccoli or sulforaphane: Is it the source or dose that matters?. Molecules, 2019; 24:3593.
43.
RichmanEL, CarrollPR, ChanJM. Vegetable and fruit intake after diagnosis and risk of prostate cancer progression. Int J Cancer, 2012; 131:201.
44.
ZhangS, SugawaraY, ChenS, et al.Mushroom consumption and incident risk of prostate cancer in Japan: A pooled analysis of the Miyagi Cohort Study and the Ohsaki Cohort Study. Int J Cancer, 2020; 146:2712–2720.
45.
SumiyoshiY, HashineK, KakehiY, et al.Dietary administration of mushroom mycelium extracts in patients with early stage prostate cancers managed expectantly: A Phase II Study. Jpn J Clin Oncol, 2010; 40:967–972.
46.
McGrowderD, Tulloch-ReidMK, CoardKCM, et al.Vitamin D deficiency at diagnosis increases all-cause and prostate cancer-specific mortality in Jamaican men. Cancer Control, 2022; 29:10732748221131224.
47.
StroombergHV, VojdemanFJ, MadsenCM, et al.Vitamin D levels and the risk of prostate cancer and prostate cancer mortality. Acta Oncol, 2021; 60:316–322.
48.
MarshallDT, SavageSJ, Garrett-MayerE, et al.Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J Clin Endocrinol Metab, 2012; 97:2315–2324.
49.
MoussaH, Nguile-MakaoM, RobitailleK, et al.Omega-3 fatty acids survey in men under active surveillance for prostate cancer: From intake to prostate tissue level. Nutrients, 2019; 11:1616.
50.
CampbellRA, LiJ, MaloneL, et al.Correlative analysis of vitamin D and omega-3 fatty acid intake in men on active surveillance for prostate cancer. Urology, 2021; 155:110–116.
51.
PatelA V., FriedenreichCM, MooreSC, et al.American College of Sports Medicine Roundtable Report on physical activity, sedentary behavior, and cancer prevention and control. Med Sci Sports Exerc, 2019; 51:2391–2402.
52.
KangDW, FaireyAS, BouléNG, et al.A randomized trial of the effects of exercise on anxiety, fear of cancer progression and quality of life in prostate cancer patients on active surveillance. J Urol, 2022; 207:814–822.
53.
KangDW, BouléNG, FieldCJ, et al.Effects of supervised high-intensity interval training on motivational outcomes in men with prostate cancer undergoing active surveillance: Results from a randomized controlled trial. Int J Behav Nutr Phys Act, 2022; 19.
54.
BrassettiA, FerrieroM, NapodanoG, et al.Physical activity decreases the risk of cancer reclassification in patients on active surveillance: A multicenter retrospective study. Prostate Cancer Prostatic Dis, 2021; 24:1151–1157.
55.
ThurtleD, JenkinsV, FreemanA, et al.Clinical impact of the predict prostate risk communication tool in men newly diagnosed with nonmetastatic prostate cancer: A Multicentre Randomised Controlled Trial. Eur Urol, 2021; 80:661–669.
56.
ResnickMJ, LacchettiC, PensonDF. Prostate cancer survivorship care guidelines: American Society of Clinical Oncology practice guideline endorsement. J Oncol Pract, 2015; 11:e445–e449.
57.
DaubenmierJJ, WeidnerG, MarlinR, et al.Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance. Urology, 2006; 67:125–130.
58.
ThomasR, WilliamsM, SharmaH, et al.A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer—The UK NCRN Pomi-T study. Prostate Cancer Prostatic Dis, 2014; 17:180.
59.
ThederanI, PottA, KruegerA, et al.Feasibility, acceptability, and behavioral outcomes of a multimodal intervention for prostate cancer patients: Experience from the MARTINI lifestyle program. Prostate, 2023; 83:929–935.
60.
BaguleyBJ, AdlardK, JenkinsD, et al.Mediterranean style dietary pattern with high intensity interval training in men with prostate cancer treated with androgen deprivation therapy: A Pilot Randomised Control Trial. Int J Environ Res Public Health, 2022; 19:5709.
61.
Hackshaw-McgeaghLE, PenfoldC, ShinglerE, et al.Phase II randomised control feasibility trial of a nutrition and physical activity intervention after radical prostatectomy for prostate cancer. BMJ Open, 2019; 9:e029480.
62.
PaurI, LillebyW, BøhnSK, et al.Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA. Clin Nutr, 2017; 36:672–679.
